Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Alzheimer´s Disease”

19 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 19 results

Not applicableLooking for participantsNCT06924359
What this trial is testing

Multimodal Ophthalmic Imaging and Plasma Biomarkers for the Early Detection of Alzheimer's Disease

Who this might be right for
Alzheimer's Disease (AD)
Peking University First Hospital 200
Not applicableLooking for participantsNCT06792877
What this trial is testing

Mindfulness for Cognition in Early-stage Alzheimer's Disease

Who this might be right for
Mild Cognitive Impairment (MCI)Mild Cognitive Impairment (MCI) Due to Alzheimer's DiseaseTBI (Traumatic Brain Injury)+3 more
VA Boston Healthcare System 100
Not applicableLooking for participantsNCT06871839
What this trial is testing

The Clinical Study of Synaptic Plasticity-based Lencanumab for the Treatment of Early Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseLecanemabFunctional Magnetic Resonance Imaging
Cuibai Wei，Clinical Professor 120
Early research (Phase 1)Not Yet RecruitingNCT06774261
What this trial is testing

Phenserine on the Alzheimer's Treatment Horizon, Study 1

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment
Helse Stavanger HF 16
Large-scale testing (Phase 3)Active Not RecruitingNCT04777396
What this trial is testing

A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)

Who this might be right for
Early Alzheimer's Disease
Novo Nordisk A/S 1,840
Testing effectiveness (Phase 2)Active Not RecruitingNCT06874621
What this trial is testing

VY7523-102: Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study in Participants With Early Alzheimer's Disease

Who this might be right for
Alzheimer's Disease (AD)
Voyager Therapeutics 52
Not applicableLooking for participantsNCT06803784
What this trial is testing

Discovery and Validation of Protein Structural Complexes in Circulating Biofluids As Novel Biomarkers for Early Diagnosis, Prognosis and Therapeutic Management of Patients Affected by Neurodegenerative Disorders

Who this might be right for
Parkinson DiseaseAmyotrophic Lateral Sclerosis (ALS)Frontotemporal Dementia (FTD)+1 more
Neuromed IRCCS 110
Not applicableStudy completedNCT01867346
What this trial is testing

Early Markers of Cognitive Change and Alzheimer s Disease

Who this might be right for
Alzheimer's Disease
National Institute on Aging (NIA) 2,850
Large-scale testing (Phase 3)Ended earlyNCT02245737
What this trial is testing

An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease

Who this might be right for
Alzheimer´s Disease
AstraZeneca 2,218
Not applicableLooking for participantsNCT07138677
What this trial is testing

Safty and Efficacy of MCI Network Guided TMS for Early Alzheimer's Disease: A Randomized, Double-blind Trial

Who this might be right for
Alzheimer's DiseaseTranscranial Magnetic StimulationIndividualized Navigation
Anhui Medical University 40
Large-scale testing (Phase 3)Active Not RecruitingNCT04777409
What this trial is testing

A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)

Who this might be right for
Early Alzheimer´s Disease
Novo Nordisk A/S 1,840
Not applicableStudy completedNCT06898424
What this trial is testing

Impact of Ketoflex 12/3 Diet on Early-to-Mid Stage Alzheimer's Progression

Who this might be right for
Alzheimer Type DementiaAlzheimer's Disease (AD)
Prof. Lutfu Hanoglu, MD 60
Not applicableNot Yet RecruitingNCT06868030
What this trial is testing

Efficacy and Safety of Conventional Symptomatic Drugs Combined with Lencanizumab in the Treatment of Early Alzheimer's Disease: a Multicenter, Prospective, Observational Study

Who this might be right for
Alzheimer's DiseaseMCI-AD, Early Stage Alzheimer's Disease
First Hospital of China Medical University 120
Not applicableNot Yet RecruitingNCT07196592
What this trial is testing

Development of a Novel Multidimensional Therapeutic Intervention Protocol for MCI

Who this might be right for
MCI-AD, Early Stage Alzheimer's Disease
Yuan Shen 300
Not applicableStudy completedNCT02224326
What this trial is testing

Vagus Somatosensory Evoked Potentials and Near-infrared Spectroscopy in the Early Diagnosis of Dementia

Who this might be right for
Alzheimer´s Disease
University of Wuerzburg 604
Large-scale testing (Phase 3)Study completedNCT00951834
What this trial is testing

Sunphenon EGCg (Epigallocatechin-Gallate) in the Early Stage of Alzheimer´s Disease

Who this might be right for
Alzheimer's Disease
Charite University, Berlin, Germany 21
Not applicableLooking for participantsNCT06730438
What this trial is testing

Transcranial Pulse Stimulation. a Potential Treatment for Early Dementia

Who this might be right for
Alzheimer Disease
Francesca Pistoia 100
Early research (Phase 1)Study completedNCT07187141
What this trial is testing

Nasal Protollin in Early Symptomatic Alzheimer's Disease

Who this might be right for
Alzheimer Disease (AD)
Brigham and Women's Hospital 16
Not applicableStudy completedNCT06965816
What this trial is testing

Using Neuroimaging to Early Diagnose Alzheimer's Disease Through Hippocampal Atrophy Assessment

Who this might be right for
Alzheimer's DiseaseHippocampusBrain Atrophy+4 more
Centre Hospitalier de Saint-Denis 85